CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $219,000 | +43.1% | 6,476 | -1.0% | 0.00% | – |
Q1 2021 | $153,000 | -22.3% | 6,543 | -4.4% | 0.00% | – |
Q4 2020 | $197,000 | +42.8% | 6,843 | 0.0% | 0.00% | – |
Q3 2020 | $138,000 | -39.7% | 6,843 | -10.3% | 0.00% | – |
Q2 2020 | $229,000 | +143.6% | 7,632 | +154.7% | 0.00% | – |
Q1 2020 | $94,000 | -36.1% | 2,997 | -4.2% | 0.00% | – |
Q4 2019 | $147,000 | +764.7% | 3,129 | +15.5% | 0.00% | – |
Q3 2019 | $17,000 | -37.0% | 2,708 | 0.0% | 0.00% | – |
Q2 2019 | $27,000 | -27.0% | 2,708 | 0.0% | 0.00% | – |
Q1 2019 | $37,000 | +640.0% | 2,708 | +136.9% | 0.00% | – |
Q4 2018 | $5,000 | -37.5% | 1,143 | 0.0% | 0.00% | – |
Q3 2018 | $8,000 | – | 1,143 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP, LLC | 3,034,083 | $41,112,000 | 40.71% |
Svennilson Peter | 4,677,939 | $63,386,000 | 33.76% |
VHCP Management II, LLC | 726,677 | $9,846,000 | 2.88% |
Casdin Capital, LLC | 1,556,999 | $21,097,000 | 2.32% |
Cormorant Asset Management, LP | 1,271,687 | $17,231,000 | 1.16% |
VHCP Management III, LLC | 66,667 | $903,000 | 0.53% |
Hillhouse Capital Management | 317,921 | $4,308,000 | 0.18% |
Orbimed Advisors | 835,842 | $11,326,000 | 0.18% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 66,186 | $897,000 | 0.13% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 253,400 | $3,434,000 | 0.13% |